UNSPSC 85724066: Supplement right hip joint with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right hip joint with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SU947Z

UNSPSC 85724066 Supplement right hip joint with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows no relevant recent activity in state and local procurement. The six most recent opportunities posted under or near this code—independent medical evaluation services, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—are all administrative healthcare services, managed-care contracting, or personnel staffing that bear no connection to orthopedic joint implant procurement or surgical procedure supply. The nominal code scope (a specific surgical implant and approach for hip replacement) does not align with what state and local governments are actually requesting under this classification.

State and local health systems, counties, and municipal retirement offices are instead buying healthcare administration, staffing augmentation, and benefits management rather than medical devices or surgical supplies. The City of Phoenix Retirement Office, Washington State Department of Transportation, and County of Santa Clara Health System are soliciting services—medical evaluation administration, occupational health surveillance, and temporary clinical staffing—that fall outside the device and implant space entirely. No recent state or local RFP, RFQ, IFB, or ITB visible in current procurement activity is requesting orthopedic implants, joint supplements, or related surgical devices under this or adjacent codes. This code warrants close monitoring for activity shift, but current sourcing patterns do not support near-term pursuit within the orthopedic implant market.